Malignant Bile Duct Obstruction: Role of a Multidisciplinary Team

Abstract

Malignant bile duct obstruction (MBDO) can occur in patients with both primary liver cancers and metastatic disease and can be a cause of significant morbidity. Laboratory abnormalities or symptoms often prompt decompression to lower bilirubin for chemotherapy, treat cholangitis, and divert bile to treat a leak or alleviate pruritus. Intervention may also be undertaken to perform biopsy or provide access to intraductal therapies such as brachytherapy, photodynamic therapy, or radiofrequency ablation. There are multiple ways to achieve biliary decompression including percutaneous procedures performed by interventional radiologists, endoscopic procedures performed by advanced endoscopists, and biliary bypass performed by hepatobiliary surgeons. Which approach is undertaken depends on several factors including the performance status, life expectancy, level of obstruction, anatomy, and patient preference. Every intervention has inherent risks as well as potential benefits, and a review of these complex patients by a multidisciplinary team ensures all options are considered. Finally, some cases require the technique and expertise of more than one specialty to achieve the desired outcome. This article highlights the importance of a multidisciplinary team in dealing with MBDOs.

Keywords

biliary obstruction - malignant - multidisciplinary

Publikationsverlauf

Eingereicht: 19. November 2024

Angenommen: 17. Dezember 2024

Artikel online veröffentlicht:
11. Februar 2025

• References

• 1 Basta YL, Bolle S, Fockens P, Tytgat KMAJ. The value of multidisciplinary team meetings for patients with gastrointestinal malignancies: a systematic review. Ann Surg Oncol 2017; 24 (09) 2669-2678
• 2 Hann LE, Getrajdman GI, Brown KT. et al. Hepatic lobar atrophy: association with ipsilateral portal vein obstruction. AJR Am J Roentgenol 1996; 167 (04) 1017-1021
• 3 Canakis A, Tyberg A. Endoscopic ultrasound-guided biliary drainage (EUS-BD). Gastrointest Endosc Clin N Am 2024; 34 (03) 487-500
• 4 Camacho JC, Brody LA, Covey AM. Treatment of malignant bile duct obstruction: what the interventional radiologist needs to know. Semin Intervent Radiol 2021; 38 (03) 300-308
• 5 Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 1975; 140 (02) 170-178
• 6 Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992; 215 (01) 31-38
• 7 Yang H, Deng J, Hu Y, Hong J. Meta-analysis on clinical outcomes of suprapapillary versus transpapillary stent insertion in malignant biliary obstruction. Surg Endosc 2023; 37 (11) 8178-8195
• 8 Thornton RH, Frank BS, Covey AM. et al. Catheter-free survival after primary percutaneous stenting of malignant bile duct obstruction. AJR Am J Roentgenol 2011; 197 (03) W514-8
• 9 Rerknimitr R, Angsuwatcharakon P, Ratanachu-ek T. et al; Asia-Pacific Working Group on Hepatobiliary Cancers. Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma. J Gastroenterol Hepatol 2013; 28 (04) 593-607
• 10 Thornton RH, Ulrich R, Hsu M. et al. Outcomes of patients undergoing percutaneous biliary drainage to reduce bilirubin for administration of chemotherapy. J Vasc Interv Radiol 2012; 23 (01) 89-95
• 11 Yang J, Wang J, Zhou H. et al. Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial. Endoscopy 2018; 50 (08) 751-760
• 12 Nennstiel S, Freivogel K, Faber A. et al. Endoscopic and percutaneous biliary interventions in patients with altered upper gastrointestinal anatomy - the Munich Multicenter Experience. Surg Endosc 2021; 35 (12) 6853-6864
• 13 Yoon SB, Yang MJ, Shin DW. et al. Endoscopic ultrasound-rendezvous versus percutaneous-endoscopic rendezvous endoscopic retrograde cholangiopancreatography for bile duct access: systematic review and meta-analysis. Dig Endosc 2024; 36 (02) 129-140